Research Articles | Page 21 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Letter to the Editor: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality Jul 2020 Leukemia Myelodysplastic Syndromes (MDS)
Long term survivors in severe aplastic anemia: standard mortality rates now comparable to controls? Jul 2023 Haematologica Aplastic Anemia
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study Dec 2023 Blood Advances Aplastic Anemia
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial Jul 2024 Lancet Haematology Myelodysplastic Syndromes (MDS)
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes Aug 2020 Cancer Myelodysplastic Syndromes (MDS)
Lowering the boom on lower-risk myelodysplastic syndromes Dec 2019 Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies Mar 2024 Expert Opinion on Biological Therapy Myelodysplastic Syndromes (MDS)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Jan 2020 The New England Journal of Medicine Myelodysplastic Syndromes (MDS)
Luspatercept in the treatment of lower-risk myelodysplastic syndromes Jan 2021 Future Oncology (London, England) Myelodysplastic Syndromes (MDS)
Luspatercept use for lower risk myelodysplastic syndromes: Active but not enough Jun 2023 American Journal of Hematology Myelodysplastic Syndromes (MDS)